Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss-Reference-Cited by-同舟云学术

Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss

Published:2019-04-08 Issue:9 Volume:20 Page:1123-1134
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Fontalis Andreas¹²,Kenanidis Eustathios³⁴,Kotronias Rafail Angelos⁵,Papachristou Afroditi⁶,Anagnostis Panagiotis⁴⁷,Potoupnis Michael³⁴,Tsiridis Eleftherios³⁴

Affiliation:

1. Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK

2. Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, UK

3. Academic Orthopaedic Unit, Aristotle University Medical School, Papageorgiou General Hospital, Thessaloniki, Greece

4. Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI), Aristotle University of Thessaloniki, Thessaloniki, Greece

5. Division of Cardiovascular Medicine, Oxford University Clinical Academic Graduate School, University of Oxford, Oxford, UK

6. Pharmacy Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

7. Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynaecology, Aristotle University Medical School, Thessaloniki, Greece

Funder

funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1594772

Reference124 articles.

1. Rosen H, Drezner M. Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women - UpToDate [Internet]. 2018 [cited 2018 Nov 7]. Available from: https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-postmenopausal-women?search=osteoporosis&source=search_result&selectedTitle=3~150&usage_type=default&display_rank=3

2. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013

3. Clinician’s Guide to Prevention and Treatment of Osteoporosis

4. Denosumab (Prolia). Denosumab treatment to increase bone mass men with osteoporosis high risk fracture or who have fail. or are intolerant to other available osteoporosis therapy. Ottawa(ON): Canadian Agency for Drugs and Technologies in Health; 2015.

5. Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypomethylation of the RUNX2 Gene Is a New Potential Biomarker of Primary Osteoporosis in Men and Women;International Journal of Molecular Sciences;2024-07-03

2. Differences in Vertebral Morphology and bone Mineral Density between Grade 1 Vertebral Fracture and Non-Fractured Participants in the Chinese Population;Calcified Tissue International;2024-03-14

3. The pathogenesis of post-stroke osteoporosis and the role oxidative stress plays in its development;Frontiers in Medicine;2023-10-19

4. Effectiveness of Selective Estrogen Receptor Modulators in Breast Cancer Therapy: An Update;Current Medicinal Chemistry;2023-09

5. Effects of resveratrol in an animal model of osteoporosis: a meta-analysis of preclinical evidence;Frontiers in Nutrition;2023-07-27